A new study from Cedars-Sinai Cancer reveals a potential way to overcome ... that share many characteristics with actual tumors. "We showed that inhibition of a gene called NPEPPS increased ...

There’s an increasing focus on using drugs to modify the tumour microenvironment, breaking down this blockade that supports tumour development and preventing penetration of cancer-killing immune ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit looks back on the progress made toward better understanding and ...

Medical experts discuss strategies for patient education on managing potential adverse events of lorlatinib and other ALK ...

This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license.

Cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) combined with endocrine therapy (ET) are the standard first-line treatment for hormone receptor-positive (HR+), human epidermal growth factor receptor ...

Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...

In most cases, however, signs of cancer eventually return ... Pretreatment with EZH2 inhibitor (bottom right) also leads to closer contact between lymphoma B cells and T cells in culture.

karolinska.se Objective To investigate the risk of breast cancer recurrence in rheumatoid arthritis (RA)—patients with tumour necrosis factor inhibitor (TNFi) treatment and a history of breast cancer, ...

A multinational team, co-led by the Garvan Institute of Medical Research, has identified a possible reason why some cancer patients treated with checkpoint inhibitor immunotherapy may become more ...